Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
J Clin Pharm Ther ; 42(4): 502-505, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28488314

ABSTRACT

WHAT IS KNOWN AND OBJECTIVE: Neuroleptic malignant syndrome (NMS) is a rare but severe adverse effect of antipsychotic drugs. CASE DESCRIPTION: We report two cases of NMS highlighted by clinical pharmacists in an emergency unit during summer. One of them was fatal. Medication reconciliation processes performed at admission identified treatment with loxapine for one of them and with loxapine and clozapine for the other. Interview of the patients highlighted clinical symptoms suggesting NMS, allowing the pharmacists to alert the medical team. WHAT IS NEW AND CONCLUSION: Adverse drug events may be severe and clinical pharmacists in emergency departments can help to detect them.


Subject(s)
Antipsychotic Agents/adverse effects , Neuroleptic Malignant Syndrome/diagnosis , Pharmacists/organization & administration , Aged , Antipsychotic Agents/administration & dosage , Clozapine/administration & dosage , Clozapine/adverse effects , Emergency Service, Hospital/organization & administration , Fatal Outcome , Humans , Loxapine/administration & dosage , Loxapine/adverse effects , Male , Middle Aged , Neuroleptic Malignant Syndrome/etiology , Pharmacy Service, Hospital/organization & administration , Professional Role
2.
Rev Med Interne ; 37(2): 84-90, 2016 Feb.
Article in French | MEDLINE | ID: mdl-26302696

ABSTRACT

PURPOSE: The diagnostic value of selective anorexia is debated. Some authors have suggested an association between meat aversion and cancer, but most do not use it as a diagnostic tool. We aimed to characterize anorexia of different diseases to search for an association between selective aversions and diagnostic groups. METHODS: All the patients admitted to three departments of a teaching hospital were included consecutively for 22months if they had more than 10 % weight loss in less than one year. Patients were excluded if history taking was not reliable, or if they suffered from anorexia nervosa. We compiled diagnoses at discharge and validated them six months later. We used logistic regression to identify independent factors associated with selective anorexia. RESULTS: Inclusion criteria were met in 106patients (female 44 %, median age 65years). Most frequent diagnoses were: cancer (36 %), infection (35 %), digestive diseases (19 %), non organic diseases (21 %). Recent selective anorexia was found in 46 % of the cases. It was significantly associated with female gender (P=0.002), marginally with young age (P=0.069) and long duration of weight loss (P=0.079). Opioid use at admission was negatively associated with selective anorexia (P=0.001). No specific diagnostic category was found to be associated. CONCLUSION: Selective anorexia does not appear to be a useful symptom to investigate pathological weight loss. It behaves more like a non-specific reactivation by current disease of earlier latent personal food aversions.


Subject(s)
Anorexia/etiology , Symptom Assessment , Taste , Weight Loss , Aged , Aged, 80 and over , Anorexia/classification , Female , Humans , Male , Middle Aged , Prospective Studies , Surveys and Questionnaires
3.
Rev Med Interne ; 31(3): 188-93, 2010 Mar.
Article in French | MEDLINE | ID: mdl-20053487

ABSTRACT

PURPOSE: Misuse of high-dose buprenorphine (HDB), mainly by injection, is responsible of frequent infectious adverse events. METHODS: This is a retrospective study of infectious complications occurring in patients using HDB by injection. Forty-two cases were identified (29 men and ten women) and the data were collected between March 1999 and December 2008. RESULTS: The infectious complications included cutaneous infections (27 cases), endocarditis (nine cases), osteoarticular infections (four spondylodiscitis and one sacroiliitis), and a vascular embolism with decrease in visual acuity. CONCLUSION: The results of HDB maintenance treatment must be improved, both from the point of view of substitution and to limit its misuse by intravenous route injection. Health professionals have to play an important role in drug addict patients' education and supervision, to prevent buprenorphine injection and related infectious complications.


Subject(s)
Bacterial Infections/etiology , Buprenorphine/administration & dosage , Injections, Intravenous/adverse effects , Injections, Subcutaneous/adverse effects , Narcotic Antagonists/administration & dosage , Abscess/etiology , Adult , Discitis/etiology , Dose-Response Relationship, Drug , Endocarditis, Bacterial/etiology , Female , Heroin Dependence/rehabilitation , Humans , Male , Retrospective Studies
4.
Acta Paediatr ; 97(10): 1358-61, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18644009

ABSTRACT

AIM: To compare the duration of treatment for neonatal abstinence syndrome (NAS) using chlorpromazine versus morphine hydrochloride. METHODS: We compared two case series of term infants with NAS treated with either morphine hydrochloride (MH) or chlorpromazine (CP). Seventeen infants were treated with MH from 1998 to 1999, and 20 infants were managed with CP from 2000 to 2001. The duration of treatment was compared, and multivariate analysis was used to identify independent risk factors related to the duration of treatment. RESULTS: Characteristics of the mothers (duration of drug addiction, abuse of other substances) and infants (birth weight, proportion breastfed) were similar in the two groups. The mean duration of CP treatment was 6 days (range 3.5-9 days), significantly fewer days than with MH treatment, which was 16 days (range 10-21 days; p < 0.001). There were fewer hospitalization days (11 days; range 9-14 days) for CP treatment compared with MH-treated infants (18 days; range 16-25 days). Treatment with CP was independently associated with shorter hospitalization time. CONCLUSION: CP appears to shorten the duration of NAS compared with MH. Larger prospective randomized trials are needed to confirm our findings.


Subject(s)
Antiemetics/therapeutic use , Chlorpromazine/therapeutic use , Dopamine Antagonists/therapeutic use , Morphine/therapeutic use , Narcotic Antagonists/therapeutic use , Neonatal Abstinence Syndrome/drug therapy , Female , Humans , Infant, Newborn , Male , Neonatal Abstinence Syndrome/therapy , Severity of Illness Index , Substance Withdrawal Syndrome/etiology , Time Factors
8.
Rev Med Interne ; 22(3): 297-303, 2001 Mar.
Article in French | MEDLINE | ID: mdl-11270274

ABSTRACT

INTRODUCTION: We report three cases of neurotoxicity in patients with renal failure, treated with Zelitrex (valacyclovir). EXEGESIS: The patients are two women and a man, aged 76 +/- 4.6 years, who presented acute mental confusion during a treatment with valacyclovir. In two cases, the patients previously had altered renal function and were under peritoneal dialysis. In the last case, the patient had simultaneous neurotoxicity and acute renal failure. After the discontinuation of the drug, the outcome was favourable in all cases. CONCLUSION: Our cases focus attention on the possible neurotoxicity of valacyclovir, which is an amino acid ester prodrug of acyclovir, rapidly and almost completely hydrolysed to acyclovir prior to systemic exposure. The bioavailability of valacyclovir is 54% compared to approximately 20% for oral acyclovir and may account for unexpected overdoses, which may lead to serious neurological toxicity.


Subject(s)
Acyclovir/analogs & derivatives , Acyclovir/adverse effects , Mental Disorders/chemically induced , Prodrugs/adverse effects , Valine/analogs & derivatives , Valine/adverse effects , Acyclovir/pharmacokinetics , Aged , Aged, 80 and over , Biological Availability , Drug Overdose , Female , Humans , Male , Prodrugs/pharmacokinetics , Renal Insufficiency/drug therapy , Valacyclovir , Valine/pharmacokinetics
10.
Rev Med Interne ; 21(3): 282-4, 2000 Mar.
Article in French | MEDLINE | ID: mdl-10763190

ABSTRACT

INTRODUCTION: Venlafaxine is an antidepressant that selectively inhibits serotonin reuptake and is a norepinephrine inhibitor. Withdrawal syndromes can occur after abrupt drug discontinuation of long-term regimens. EXEGESIS: We report six cases of withdrawal symptoms after venlafaxine discontinuation. CONCLUSION: Physicians must be aware of the frequency, rapidity and potent severity of these withdrawal syndromes.


Subject(s)
Antidepressive Agents, Second-Generation/adverse effects , Cyclohexanols/adverse effects , Selective Serotonin Reuptake Inhibitors/adverse effects , Substance Withdrawal Syndrome/etiology , Adult , Akathisia, Drug-Induced/etiology , Depressive Disorder/drug therapy , Fatigue/chemically induced , Female , Gastrointestinal Diseases/chemically induced , Hallucinations/chemically induced , Headache/chemically induced , Humans , Male , Middle Aged , Paresthesia/chemically induced , Substance Withdrawal Syndrome/diagnosis , Time Factors , Venlafaxine Hydrochloride
14.
Ann Med Interne (Paris) ; 146(7): 505-9, 1995.
Article in French | MEDLINE | ID: mdl-8787293

ABSTRACT

The treatment and the prevention of Pneumocystis carinii pneumonia (PCP) is based on trimethoprim-sulfamethoxazole. However, hypersensitivity reactions occur often in HIV-infected patients. In this study, clinical and biological parameters of 27 PCP-patients treated by this drug association were analyzed. We divided the drug reactions into two groups according to the severity. A drug reaction occurred in 59.2% of the patients and was note as a mild reaction in 18.5% of the cases and as a severe reaction in 40.7%. An initial high eosinophil count was noted in patients who may present future drug reaction. This difference was more significant in patients who may present severe drug reaction. No other clinical or biological factors were predictive of hypersensitivity. The immune status of HIV-disease, drug therapy, and drug mechanisms were discussed.


Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , Drug Hypersensitivity/etiology , Pneumonia, Pneumocystis/drug therapy , Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects , Adult , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Retrospective Studies , Risk Factors
17.
Arch Mal Coeur Vaiss ; 86(1): 27-34, 1993 Jan.
Article in French | MEDLINE | ID: mdl-8338397

ABSTRACT

The prognosis of right ventricular failure in patients with mitral valve disease would seem to depend on its chronicity and progression according to the results of a study of 382 cases of mitral valve disease: 231 women, 151 men: average age 55 +/- 13 years, operated between January 1983 and December 1986, most (321) for mitral valve replacement, one third (108) with associated aortic valve replacement. Right ventricular failure was or had been present before surgery in 161 patients: the peri-operative mortality was 11.2% and the secondary mortality 21.7% in these cases, significantly higher than in patients without RVF (respectively 5.0%, p = 0.02, and 8.1%, p < 0.0005). The RVF was present in the immediate post-operative phase in 43 patients, 8 of whom had no signs of this complication beforehand. The cause of this "de novo" early RVF is multifactorial. Ten other patients developed secondary RVF without any obvious cause in 3 cases. The prognosis of "de novo" RVF is very poor (28% survivors at 75 months). At the end of 60.4 +/- 13.6 months 20 patients were lost to follow-up, RVF was present in 60/286 patients followed up. The mortality was high in the patients with residual RVF (38.3% vs 4.0% in patients without: p < 0.0001). This study confirms the poor prognosis of RVF in patients with mitral valve disease whatever the timing with respect to surgery. Right ventricular failure occurring for the first time after surgery is rare (4.7% of cases), of uncertain cause, and carries a particularly poor prognosis.


Subject(s)
Heart Failure/etiology , Heart Valve Diseases/complications , Heart Valve Prosthesis/adverse effects , Ventricular Function, Right , Actuarial Analysis , Adult , Aged , Aortic Valve/surgery , Female , Heart Failure/mortality , Heart Valve Diseases/surgery , Humans , Male , Middle Aged , Mitral Valve/surgery , Prognosis , Retrospective Studies , Survival Rate
19.
Pathol Res Pract ; 188(4-5): 466-72, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1409073

ABSTRACT

In this prospective study, an image cytometric DNA-analysis was performed in 86 women with breast neoplasms (72 primary invasive carcinomas and 14 benign lesions). Four DNA ploidy parameters were analysed: histogram type (according to AUER classification), DNA-index, tumor cells with DNA content above the 5n limit and DNA malignancy grade (DNA-MG, calculation according to Böcking). Their correlations with well established prognostic factors in breast carcinomas (tumor size, lymph node status, histologic grade, hormone receptor content) were studied. All but one benign lesions were diploid (13/14 cases), whereas the majority of the primary invasive breast carcinomas were aneuploid (58/72 cases). A predominance of carcinomas with a percentage of cells superior or equal to 1% with DNA content above the 5n limit was observed (54 cases out of 58). Most of the aneuploid tumors had a histogram type III or IV (53 cases) or a high DNA-index (50 cases). Of these 58 aneuploid cases, only 26 tumors had a DNA-MG superior to 1. Interestingly, 26 tumors had the 4 criteria of aneuploidy, 19 had 3 and 9 had 2 and only 4 tumors had one parameter. The DNA-MG was significantly related to hormonal receptors (p less than 0.001) and tumor size (p less than 0.01). The histogram types (Auer classification) and the DNA content above the 5n limit were correlated with histologic grade (SBR or SBRM) (p less than 0.02). Concerning the DNA-index no correlation was observed with well established prognostic factors. On the other hand no significant correlation was found between these new biologic variables and lymph node status.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Aneuploidy , Breast Neoplasms/genetics , Carcinoma, Transitional Cell/genetics , DNA, Neoplasm/analysis , Adolescent , Adult , Aged , Aged, 80 and over , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Carcinoma, Transitional Cell/epidemiology , Carcinoma, Transitional Cell/pathology , Female , Flow Cytometry/methods , Humans , Image Processing, Computer-Assisted/methods , Lymph Nodes/pathology , Middle Aged , Ploidies , Prospective Studies , S Phase
SELECTION OF CITATIONS
SEARCH DETAIL
...